Walnut Level Capital LLC Purchases 30,000 Shares of The Chemours Company (NYSE:CC)

Walnut Level Capital LLC lifted its position in shares of The Chemours Company (NYSE:CC) by 60.0% during the 4th quarter, HoldingsChannel reports. The firm owned 80,000 shares of the specialty chemicals company’s stock after acquiring an additional 30,000 shares during the period. Chemours accounts for about 0.5% of Walnut Level Capital LLC’s investment portfolio, making the stock its 28th biggest holding. Walnut Level Capital LLC’s holdings in Chemours were worth $1,352,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its position in shares of Chemours by 99.7% during the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 765 shares in the last quarter. Truvestments Capital LLC bought a new stake in Chemours in the third quarter worth $35,000. Brooklyn Investment Group bought a new stake in Chemours in the third quarter worth $37,000. KBC Group NV boosted its holdings in Chemours by 38.2% in the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock worth $104,000 after acquiring an additional 1,708 shares in the last quarter. Finally, EMC Capital Management boosted its holdings in Chemours by 74.6% in the fourth quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company’s stock worth $161,000 after acquiring an additional 4,073 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CC has been the topic of several analyst reports. Truist Financial initiated coverage on Chemours in a report on Tuesday, January 28th. They issued a “buy” rating and a $27.00 target price on the stock. Mizuho dropped their target price on Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. The Goldman Sachs Group dropped their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Finally, Barclays decreased their price target on Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research note on Monday, February 24th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, Chemours currently has an average rating of “Hold” and a consensus target price of $23.11.

Chemours Stock Down 3.6 %

Chemours stock opened at $14.14 on Monday. The stock has a market cap of $2.11 billion, a PE ratio of 24.80 and a beta of 2.00. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The Chemours Company has a one year low of $13.09 and a one year high of $29.21. The stock has a fifty day moving average of $16.89 and a 200 day moving average of $18.32.

Chemours (NYSE:CC) last posted its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. The company had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. As a group, sell-side analysts predict that The Chemours Company will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 7.07%. The ex-dividend date was Friday, February 28th. Chemours’s dividend payout ratio (DPR) is presently 175.44%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.